Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Research Article Volume 6 Issue 1

Prevelance of Ovarian Cancer and its Correlation with Age in Pakistan

Muhammad Waqar Mazhar*, Muhammad Irfan, Abdul Manan, Saira Saif, Wajeeha Iram and Sohail Ansari

Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan

*Corresponding Author: Muhammad Waqar Mazhar, Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan.

Received: November 15, 2021; Published: December 20, 2021


Introduction: group of diseases that is originated from the different parts of ovaries and cause production of abnormal cells that divide uncontrolled themselves in the ovaries is known as ovarian cancer. OC is mainly classified into majorly three types on the base of three components of ovaries known as epithelium, stroma and germinal cells. Approximately, 7000 women develop OC and 4200 of them die every year in UK. In Pakistan the incidence of OC is increasing at the rate of around 13.6%. Approximately 70% cases are diagnosed at later stages.

Methodology: The blood sample was collected by Layyah region. The CA125 identification through Elisa technique for their better identification on the basis of antibodies. Normal values of CA125 were considered less than 35 U/ml. the other tumor marker was also measured such as fibrinogen, prolactin, CA15.3, PT, APTT, INR, D Dimer, and CA19.9.

Results: The mean age of patients was 59.0 ± 8.1while the minimum and maximum age at which the tumor marker detection was 22 and 74 years. The no of patient was found in order of 25 > 24 > 10 in 1st, 2nd and 3rd age groups, respectively. The clinical histopathological test in the ovarian cancer patients show that the tumor size 5.21 ± 3.42, fibrinogen 5.09 ± 1.29, CA-199 (U/mL) 121.17 ± 59.76, and D-dimer 0.61 ± 0.31. The CA-125 level increase in ovarian cancer patients it indication as a tumor marker.

Keywords: Ovarian Cancer; CA-125; Transvaginal Ultrasound; Prolactin Level; CA19.9


  1. Williams TI., et al. “Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers”. Journal of Proteome Research 8 (2007): 2936-2962.
  2. Melikechi N., et al. “Age-specific discrimination of blood plasma samples of healthy and ovarian cancer prone mice using laser-induced breakdown spectroscopy”. Spectrochimica Acta Part B: Atomic Spectroscopy123 (2016): 33-41.
  3. Jayson GC., et al. “Ovarian cancer”. The Lancet9951 (2014): 1376-1388.
  4. Sung H., et al. “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians3 (2021): 209-249.
  5. Shimosato Y., et al. “Tumors of the mediastinum”. Amer Registry of Pathology (2010).
  6. Xing F., et al. “The expression of microRNA-598 inhibits ovarian cancer cell proliferation and metastasis by targeting URI”. Molecular Therapy-Oncolytics 12 (2019): 9-15.
  7. Andrews L and DG Mutch. “Hereditary ovarian cancer and risk reduction”. Best Practice and Research Clinical Obstetrics and Gynaecology 41 (2017): 31-48.
  8. Olsen CM., et al. “Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium”. Endocrine-Related Cancer2 (2013): 251-262.
  9. Allen PL. “Prospective study of symptoms of ovarian cancer in postmenopausal women”. UCL (University College London).
  10. Katzke VA., et al. “Lifestyle and cancer risk”. The Cancer Journal2 (2015): 104-110.
  11. Omoyajowo KO., et al. “Awareness of Toxicological Impact and Risk of using Talcum Powder as a factor for Ovarian Cancer among Women in three Metropolitan Cities of Southwestern States of Nigeria (2021).
  12. Modugno F., et al. “Breastfeeding factors and risk of epithelial ovarian cancer”. Gynecologic Oncology 153.1 (2019): 116-122.


Citation: Muhammad Waqar Mazhar., et al. “Prevelance of Ovarian Cancer and its Correlation with Age in Pakistan" 6.1 (2022): 06-09.


Copyright: © 2022 Muhammad Waqar Mazhar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
    Use KmsPico to obtain a Windows and Office license.

Contact US